Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 8
Submit an article Journal homepage
544
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Treatment strategies for central nervous system infections

Kwang Sik Kim Johns Hopkins University School of Medicine, Division of Pediatric Infectious Diseases, 200 North Wolfe Street, Room 3157, Baltimore, MD 21287, USA +1 410 614 3917; +1 410 614 1491; [email protected]
Pages 1307-1317 | Published online: 15 May 2009

Bibliography

  • World Health Organization. World health report: changing history. Geneva: WHO, 2004
  • Klinger G, Chin C-N, Beyene J, Perlman M. Predicting the outcome of neonatal bacterial meningitis. Pediatrics 2000;106:477-82
  • Stevens JP, Eames M, Kent A, et al. Long-term outcome of neonatal meningitis. Arch Dis Child Fetal Neonatal Ed 2003;88:F179-84
  • Chang CJ, Chang WN, Huang LT, et al. Bacterial meningitis in infants: the epidemiology, clinical features, and prognostic factors. Brain Dev 2004;26:168-75
  • Van De Beek D, De Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849-59
  • Weisfelt M, Van De Beek D, Spanjaard L, et al. A risk score for unfavorable outcome in adults with bacterial meningitis. Ann Neurol 2008;63:90-7
  • Kim KS. Pathogenesis of bacterial meningitis: from bacteremia to neuronal injury. Nature Rev Neurosci 2003;4:376-85
  • Fothergill LD, Wright J. Influenzal meningitis: the relation of age incidence to the bactericidal power of blood against the causal organism. J Immunol 1933;24:273-84
  • Chudwin DS, Wara DW, Lameris-Martin NB, Ammann AJ. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19. Proc Soc Exp Biol Med 1983;172:178-86
  • Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969;129:1307-26
  • Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998;102:1087-97
  • Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753-6
  • Schiff DE, Wass CA, Cryz SJ Jr, et al. Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection. Infect Immun 1993;61:974-80
  • Kim KS, Itabashi H, Gemski P, et al. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J Clin Invest 1992;90:897-905
  • Ferrieri P, Burke B, Nelson J. Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect Immun 1980;27:1023-32
  • Kim KS. Effect of antimicrobial therapy for experimental infections due to group B streptococcus on mortality and clearance of bacteria. J Infect Dis 1987;155:1233-41
  • Dietzman DE, Fischer GW, Schoenknecht FD. Neonatal Escherichia coli septicemiabacterial counts in blood. J Pediatr 1974;85:128-30
  • Bell LM, Alpert G, Campos JM, Plotkin SA. Routine blood cultures in children with Jeamophilus influenzae or Strptococcus pneumoniae bactermia. Pediatrics 1985;76:901-4
  • Sullivan TD, Lascolea LJ Jr, Neter E. Relationship between the magnitude of bacteremia in children and the clinical outcome. Pediatrics 1982;69:699-702
  • Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997;337:970-6
  • Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of proteinpolysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46
  • Tsai CJ, Griffin MR, Pekka Nuorti J, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 2008;46:1664-72
  • Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006;354:1455-63
  • Park SY, Moore MR, Bruden DL, et al. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J 2008;27:335-40
  • Jacobs MR. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther 2008;6:619-35
  • Borrow R, Miller E. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned. Expert Rev Vaccines 2006;5:851-7
  • Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009;360:244-56
  • Andersen J, Backer V, Voldsgaard P, et al. Acute meningococcal meningitis: analysis of features of the disease according to the age of 255 patients. Copenhagen Meningitis Study Group. J Infect 1997;34:227-35
  • Thomas KE, Hasbun R, Jekel J, Quagliarello VJ. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis 2002;35:46-52
  • Wong M, Wong E, Fried D. Diseases that mimic meningitis. Analysis of 650 lumbar punctures. Clin Pediatr 1990;29:254-5, 258-61
  • Geiseler PJ, Nelson KE. Bacterial meningitis without clinical signs of meningeal irritation. South Med J 1982;75:448-50
  • La Scolea LJ Jr, Dryja D. Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J Clin Microbiol 1984;19:187-90
  • Bingen E, Lambert-Zechovsky N, Mariani-Kurkdjian P, et al. Bacterial counts in cerebrospinal fluid of children with meningitis. Eur J Clin Microbiol Infect Dis 1990;9:278-81
  • Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes, 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine 1998;77:313-36
  • Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev 1992;5:130-45
  • American Academy of Pediatrics. Red Book: 2006 Report of the Committee on infectious diseases, 27th edition. In: Pickering LK, editor, Elk Grove Village, IL: American Academy of Pediatrics, 2006. pp. 312-14, pp. 455-7
  • Rubin LL, Staddon JM. The cell biology of the blood–brain barrier. Annu Rev Neurosci 1999;22:11-28
  • Sinner SW, Tunkel AR. Antimicrobial agents in the treatment of bacterial meningitis. Infect Dis Clin N Am 2004;18:581-602
  • Loscher W, Potschka H. Role for drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 2005;76:22-76
  • Hieber JP, Nelson JD. A pharmacologic evaluation of penicillin in children with purulent meningitis. N Engl J Med 1977;297:410-13
  • Ahmed A, Jafri H, Lutsar I, et al. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1999;43:876-81
  • Kim KS. Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis. Antimicrob Agents Chemother 1985;28:433-6
  • Lutsar I, Ahmed A, Friedland IR, et al. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1997;41:2414-17
  • McGeary SA, Kim KS, Ward JI. Susceptibility of group B Streptococcus to beta-lactam antibiotics. Drugs Exp Clin Res 1983;10:693-6
  • Aronin SI, Pedruzzi P, Quagliarello VJ. Community-acquired meningitis: risk stratification for adverse outcome and effect of antibiotic timing. Ann Intern Med 1998;129:862-9
  • Miner JR, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med 2001;21:387-92
  • Proulx N, Frechette D, Toye B, et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005;98:291-8
  • Auburtin M, Wolff M, Charpentier J, et al. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 2006;34:2758-65
  • John CC. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994;18:188-93
  • Andes DR, Craig WA. Pharmacokinetics and pharmacodynamics of antibiotics in meningitis. Infect Dis Clin North Am 1999;13:595-618
  • Kim KS. Antimicrobial susceptibility of group B Streptococci. Antibiot Chemother 1985;35:83-9
  • Kimura K, Suzuki S, Wachino J-I, et al. First molecular characterization of Group B Streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008;52:2890-7
  • Dahesh S, Hensler ME, Van Sorge NM, et al. Point mutation in the Group B Streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob Agents Chemother 2008;52:2915-18
  • Latorre C, Gene A, Juncosa T, et al. Neisseria meningitidis: evolution of penicillin resistance and phenotype in a children's hospital in Barcelona, Spain. Acta Paediatr 2000;89:661-5
  • Jackson LA, Tenover FC, Baker C, et al. Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group. J Infect Dis 1994;169:438-41
  • Gerber CM, Cottagnoud M, Neftel KA, et al. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain. Eur J Clin Microbiol Infect Dis 1999;18:866-70
  • Cottagnoud P, Acosta F, Cottagnoud M, Tauber MG. Cefepime is efficacious against penicillin-and quinolone-resistant pneumococci in experimental meningitis. J Antimicrob Chemother 2002;49:327-30
  • Cottagnoud P, Pfister M, Cottagnoud M, et al. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2003;47:1943-7
  • Schmidt H, Dalhoff A, Stuertz K, et al. Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrob Agents Chemother 1998;42:1397-407
  • Lutsar I, Friedland IR, Wubbel L, et al. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1998;42:2650-5
  • Smirnov A, Wellmer A, Gerber J, et al. Gemifloxacin is effective in experimental pneumococcal meningitis. Antimicrob Agents Chemother 2000;44:767-70
  • Rodriguez-Cerrato V, Ghaffar F, Saavedra J, et al. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 2001;45:3098-103
  • Grandgirard D, Schurch C, Cottagnoud P, Leib SL. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis. Antimicrob Agents Chemother 2007;51:2173-8
  • Rodriguez-Cerrato V, McCoig CC, Saavedra J, et al. Garenoxacin (BMS-284756) and moxiiifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci. Antimicrob Agents Chemother 2003;47:211-15
  • Developmental Disabilities Br, Div of Birth Defects and Development Disabilities, National Center for Environmental Health, CDC. Postnatal causes of developmental disabilities in children aged 3–10 years, Atlanta, Georgia, 1991. MMWR 1996;45:130-4
  • Van De Beek D, De Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007;24:CD004405
  • McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997;278:925-31
  • American Academy of Pediatrics. Red Book: 2006 Report of the Committee on infectious diseases, 27th edition. In: Pickering LK, editor, Elk Grove Village, IL: American Academy of Pediatrics, 2006. p. 530
  • Brady MT, Kaplan SL, Taber LH. Association between persistence of pneumococcal meningitis and dexamethasone administration. J Pediatr 1981;99:924-6
  • Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995;39:1988-92
  • Leib SL, Heimgartner C, Bifrare YD, et al. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr Res 2003;54:353-7
  • Spreer A, Gerber J, Hanssen M, et al. Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis. Pediatr Res 2006;60:210-15
  • Peltola H, Roine I, Fernandez J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. CID 2007;45:1277-86
  • Haddy RI, Perry K, Chacko CE, et al. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J 2005;24:320-3
  • Kim KS. Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol 2008;6:625-34
  • Kim KS. Emerging molecular targets in the treatment of bacterial meningitis. Expert Opin Ther Targets 2003;7:1-12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.